These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25897235)

  • 1. Health care resource use and direct medical costs for patients with schizophrenia in Tianjin, People's Republic of China.
    Wu J; He X; Liu L; Ye W; Montgomery W; Xue H; McCombs JS
    Neuropsychiatr Dis Treat; 2015; 11():983-90. PubMed ID: 25897235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People's Republic of China.
    Zhang L; Chen Y; Yue L; Liu Q; Montgomery W; Zhi L; Wang W
    Neuropsychiatr Dis Treat; 2016; 12():941-9. PubMed ID: 27143895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care resource utilization and direct medical costs for patients with schizophrenia initiating treatment with atypical versus typical antipsychotics in Tianjin, China.
    He X; Wu J; Jiang Y; Liu L; Ye W; Xue H; Montgomery W
    BMC Health Serv Res; 2015 Apr; 15():149. PubMed ID: 25880803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare Resource Utilization and Direct Medical Costs for Patients With Osteoporotic Fractures in China.
    Wu J; Qu Y; Wang K; Chen Y
    Value Health Reg Issues; 2019 May; 18():106-111. PubMed ID: 30909083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy.
    Montgomery W; Liu L; Stensland MD; Xue HB; Treuer T; Ascher-Svanum H
    Clinicoecon Outcomes Res; 2013; 5():407-18. PubMed ID: 23983478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost reduction in hospitalization associated with paliperidone palmitate in the People's Republic of China, Korea, and Malaysia.
    Chiou CF; Wang BC; Caldwell R; Furnback W; Lee JS; Kothandaraman N; Lee S; Wang J; Zhang F
    Neuropsychiatr Dis Treat; 2015; 11():1989-94. PubMed ID: 26346330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Optimal Medical Therapy at Discharge on One-year Direct Medical Costs in Patients with Acute Coronary Syndromes: A Retrospective, Observational Database Analysis in China.
    He X; Wang Y; Cong H; Lu C; Wu J
    Clin Ther; 2019 Mar; 41(3):456-465.e2. PubMed ID: 30770126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct medical costs for patients with schizophrenia: a 4-year cohort study from health insurance claims data in Guangzhou city, Southern China.
    Zhang H; Sun Y; Zhang D; Zhang C; Chen G
    Int J Ment Health Syst; 2018; 12():72. PubMed ID: 30479658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.
    Berman S; Rannie M; Moore L; Elias E; Dryer LJ; Jones MD
    Pediatrics; 2005 Jun; 115(6):e637-42. PubMed ID: 15930189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Care Utilization and Costs of Patients With Prostate Cancer in China Based on National Health Insurance Database From 2015 to 2017.
    Bai L; Wushouer H; Huang C; Luo Z; Guan X; Shi L
    Front Pharmacol; 2020; 11():719. PubMed ID: 32587512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between suicide rate and economic growth and stock market in the People's Republic of China: 2004-2013.
    Yin H; Xu L; Shao Y; Li L; Wan C
    Neuropsychiatr Dis Treat; 2016; 12():3119-3128. PubMed ID: 27994468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The societal cost of schizophrenia in Sweden.
    Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
    J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surgical site infection following abdominal surgery in China: a multicenter cross-sectional study].
    Wang Z; Chen J; Ren J; Wang P; Jie Z; Jin W; Hu J; Li Y; Zhang J; Li S; Tu J; Zhang H; Liu H; Shang L; Zhao J; Luo S; Yao H; Jia B; Chen L; Ren Z; Li G; Zhang H; Wu Z; Wang D; Gao Y; Fu W; Yang H; Xie W; Zhang E; Peng Y; Wang S; Chen J; Zhang J; Zheng T; Wang G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1366-1373. PubMed ID: 30588587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.
    Zhang H; Zhang C; Zhu S; Ye H; Zhang D
    BMC Health Serv Res; 2020 Feb; 20(1):122. PubMed ID: 32059726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants and influencing mechanism of outpatient satisfaction: a survey on tertiary hospitals in the People's Republic of China.
    Yu W; Li M; Xue C; Wang J; Liu J; Chen H; Zhang L
    Patient Prefer Adherence; 2016; 10():601-12. PubMed ID: 27143865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
    Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
    Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Molecular Testing of Lung Cancer in Mainland People's Republic of China Over the Decade 2010 to 2019.
    Li W; Lyu Y; Wang S; Zhou X; Ma J; Xu C; Fang L; Ying J;
    JTO Clin Res Rep; 2021 Apr; 2(4):100163. PubMed ID: 34590013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions.
    Bagalman E; Muser E; Choi JC; Durden E; Macfadden W; Haskins JT; Dirani R
    Clin Ther; 2011 Oct; 33(10):1381-1390.e4. PubMed ID: 22000656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic burden of breakthrough seizures.
    Divino V; Petrilla AA; Bollu V; Velez F; Ettinger A; Makin C
    Epilepsy Behav; 2015 Oct; 51():40-7. PubMed ID: 26255884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.